Paraza Pharma Inc.
Chia-Hao Chang is a Scientist II in Cell Biology at Paraza Pharma Inc., with extensive experience in drug development and cell biology research. Since March 2021, Chia-Hao has contributed to over eight independent projects involving US-based biotechnology firms, focusing on the development of assays for targeting undruggable transcription factors and investigating the proteasome degradation pathway. Previous roles include Scientist I where Chia-Hao identified and validated over 40 pharmacodynamic markers in bladder cancer and served as a Postdoctoral Researcher at the Lady Davis Institute for Medical Research, screening exosomal miRNA targets in breast cancer. With a Ph.D. in Pharmacology from McGill University and a strong educational background including a Master's and Bachelor's in Biomedical Sciences, Chia-Hao has developed expertise in a wide range of methodologies, including CRISPR/Cas9 technology and ELISA-based assays, and has a history of supervising research projects and training users in complex microscopy techniques.
This person is not in any teams
This person is not in any offices
Paraza Pharma Inc.
1 followers
Paraza Pharma Inc. is an innovative company with an aim to significantly improve the efficiency of the drug discovery process from lead identification through lead optimization to development candidates. With an excellent team of highly creative drug discovery scientists trained in world-reputed laboratories and deep experience in drug discovery and development from pharmaceutical companies such as Merck, Pfizer, Wyeth, Boehringer-Ingelheim, AstraZeneca and Schering-Plough, we offer collaborative opportunities to provide most efficient solutions.Headquartered in the greater Montreal area, with state-of-the-art laboratories housed in a modern building, with excellent academic institutions and a world-class international airport for easy access, we provide location, talent pool and excellent communication skills to enhance the effectiveness of our collaborations.